Inactive

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Life Technologies, Corporation for HIV-1 Genotyping Kit - Amplification Mod and HIV-1 G... The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Life Technologies, Corporation for HIV-1 Genotyping Kit - Amplification Mod and HIV-1 Genotyping Kit - Cycle Sequencing. The HIV genotyping kit being procured is recommended by the World Health Organization to perform molecular testing and surveillance within resource-limited settings. This genotyping kit has been validated to detect multiple HIV subtypes and circulating recombinant forms (CRFs) of the virus in plasma and dried blood spots (DBS), the preferred sample type in resource-limited settings. This particular kit will ensure the continuity of results generated by the testing laboratory.. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at kpy3@cdc.gov by 5 p.m. 09 September 2020.